<sup>18</sup>F-fluorodeoxyglucose positron emission tomography combined with computed tomography for the prediction of radioiodine therapy response in patients with metastatic differentiated thyroid cancer
The study objective was to investigate the role of 18 F-fluorodeoxyglucose (18 F-FDG) positron emission tomography combined with computed tomography (PET-CT) as an indirect determination of the differentiation status of metastases and for the prediction of radioactive iodine (RAI) therapy response i...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2020-02-01
|
| Series: | Опухоли головы и шеи |
| Subjects: | |
| Online Access: | https://ogsh.abvpress.ru/jour/article/view/444 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850024128917012480 |
|---|---|
| author | T. M. Geliashvili A. V. Vazhenin T. P. Berezovskaya N. G. Afanasyeva E. V. Vasilyeva P. I. Garbuzov V. V. Krylov |
| author_facet | T. M. Geliashvili A. V. Vazhenin T. P. Berezovskaya N. G. Afanasyeva E. V. Vasilyeva P. I. Garbuzov V. V. Krylov |
| author_sort | T. M. Geliashvili |
| collection | DOAJ |
| description | The study objective was to investigate the role of 18 F-fluorodeoxyglucose (18 F-FDG) positron emission tomography combined with computed tomography (PET-CT) as an indirect determination of the differentiation status of metastases and for the prediction of radioactive iodine (RAI) therapy response in patients with metastatic differentiated thyroid cancer.Materials and methods. The 40 metastatic differentiated thyroid cancer patients were enrolled in the study that underwent both post-therapeutic radioiodine scan and PET-CT at the same period.Results. The study found that 12 (30 %) patients responded to RAI therapy. The remaining 28 (70 %) patients not responded to RAI therapy showed stabilization or progression. The accumulation of radioiodine by metastases positively correlated with the total response rate, while the 18 F-FDG avidity is negative. Significant direct correlation with response rate was observed in the group with only radioiodine uptake. However, this correlation was not observed in the patients with both tracers uptake. The patients with 18 F-FDG-positive metastases showed poor response to RAI therapy, regardless of the degree of radioiodine uptake.Conclusion. The 18 F-FDG uptake by metastases is a predictor of a poor response to RAI therapy, even in the presence of RAI uptake. The use of 18 F-FDG PET-CT in patients with metastatic differentiated thyroid cancer can be recommended at the beginning of RAI therapy to clarify the prognosis and provide a personalized approach to the treatment and observation of the most difficult category of patients. |
| format | Article |
| id | doaj-art-7ff77a487da14741b998b71d61c25adc |
| institution | DOAJ |
| issn | 2222-1468 2411-4634 |
| language | Russian |
| publishDate | 2020-02-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Опухоли головы и шеи |
| spelling | doaj-art-7ff77a487da14741b998b71d61c25adc2025-08-20T03:01:11ZrusABV-pressОпухоли головы и шеи2222-14682411-46342020-02-0194101610.17650/2222-1468-2019-9-4-10-16367<sup>18</sup>F-fluorodeoxyglucose positron emission tomography combined with computed tomography for the prediction of radioiodine therapy response in patients with metastatic differentiated thyroid cancerT. M. Geliashvili0A. V. Vazhenin1T. P. Berezovskaya2N. G. Afanasyeva3E. V. Vasilyeva4P. I. Garbuzov5V. V. Krylov6A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center, Ministry of Health of RussiaChelyabinsk Regional Clinical Center of Oncology and Nuclear MedicineA. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center, Ministry of Health of RussiaChelyabinsk Regional Clinical Center of Oncology and Nuclear MedicineChelyabinsk Regional Clinical Center of Oncology and Nuclear MedicineA. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center, Ministry of Health of RussiaA. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center, Ministry of Health of RussiaThe study objective was to investigate the role of 18 F-fluorodeoxyglucose (18 F-FDG) positron emission tomography combined with computed tomography (PET-CT) as an indirect determination of the differentiation status of metastases and for the prediction of radioactive iodine (RAI) therapy response in patients with metastatic differentiated thyroid cancer.Materials and methods. The 40 metastatic differentiated thyroid cancer patients were enrolled in the study that underwent both post-therapeutic radioiodine scan and PET-CT at the same period.Results. The study found that 12 (30 %) patients responded to RAI therapy. The remaining 28 (70 %) patients not responded to RAI therapy showed stabilization or progression. The accumulation of radioiodine by metastases positively correlated with the total response rate, while the 18 F-FDG avidity is negative. Significant direct correlation with response rate was observed in the group with only radioiodine uptake. However, this correlation was not observed in the patients with both tracers uptake. The patients with 18 F-FDG-positive metastases showed poor response to RAI therapy, regardless of the degree of radioiodine uptake.Conclusion. The 18 F-FDG uptake by metastases is a predictor of a poor response to RAI therapy, even in the presence of RAI uptake. The use of 18 F-FDG PET-CT in patients with metastatic differentiated thyroid cancer can be recommended at the beginning of RAI therapy to clarify the prognosis and provide a personalized approach to the treatment and observation of the most difficult category of patients.https://ogsh.abvpress.ru/jour/article/view/444<sup>18</sup> f-fluorodeoxyglucose positron emission tomography combined with computed tomographydifferentiated thyroid cancerradioiodine therapypost-therapeutic <sup>131</sup> i whole-body scintigraphy |
| spellingShingle | T. M. Geliashvili A. V. Vazhenin T. P. Berezovskaya N. G. Afanasyeva E. V. Vasilyeva P. I. Garbuzov V. V. Krylov <sup>18</sup>F-fluorodeoxyglucose positron emission tomography combined with computed tomography for the prediction of radioiodine therapy response in patients with metastatic differentiated thyroid cancer Опухоли головы и шеи <sup>18</sup> f-fluorodeoxyglucose positron emission tomography combined with computed tomography differentiated thyroid cancer radioiodine therapy post-therapeutic <sup>131</sup> i whole-body scintigraphy |
| title | <sup>18</sup>F-fluorodeoxyglucose positron emission tomography combined with computed tomography for the prediction of radioiodine therapy response in patients with metastatic differentiated thyroid cancer |
| title_full | <sup>18</sup>F-fluorodeoxyglucose positron emission tomography combined with computed tomography for the prediction of radioiodine therapy response in patients with metastatic differentiated thyroid cancer |
| title_fullStr | <sup>18</sup>F-fluorodeoxyglucose positron emission tomography combined with computed tomography for the prediction of radioiodine therapy response in patients with metastatic differentiated thyroid cancer |
| title_full_unstemmed | <sup>18</sup>F-fluorodeoxyglucose positron emission tomography combined with computed tomography for the prediction of radioiodine therapy response in patients with metastatic differentiated thyroid cancer |
| title_short | <sup>18</sup>F-fluorodeoxyglucose positron emission tomography combined with computed tomography for the prediction of radioiodine therapy response in patients with metastatic differentiated thyroid cancer |
| title_sort | sup 18 sup f fluorodeoxyglucose positron emission tomography combined with computed tomography for the prediction of radioiodine therapy response in patients with metastatic differentiated thyroid cancer |
| topic | <sup>18</sup> f-fluorodeoxyglucose positron emission tomography combined with computed tomography differentiated thyroid cancer radioiodine therapy post-therapeutic <sup>131</sup> i whole-body scintigraphy |
| url | https://ogsh.abvpress.ru/jour/article/view/444 |
| work_keys_str_mv | AT tmgeliashvili sup18supffluorodeoxyglucosepositronemissiontomographycombinedwithcomputedtomographyforthepredictionofradioiodinetherapyresponseinpatientswithmetastaticdifferentiatedthyroidcancer AT avvazhenin sup18supffluorodeoxyglucosepositronemissiontomographycombinedwithcomputedtomographyforthepredictionofradioiodinetherapyresponseinpatientswithmetastaticdifferentiatedthyroidcancer AT tpberezovskaya sup18supffluorodeoxyglucosepositronemissiontomographycombinedwithcomputedtomographyforthepredictionofradioiodinetherapyresponseinpatientswithmetastaticdifferentiatedthyroidcancer AT ngafanasyeva sup18supffluorodeoxyglucosepositronemissiontomographycombinedwithcomputedtomographyforthepredictionofradioiodinetherapyresponseinpatientswithmetastaticdifferentiatedthyroidcancer AT evvasilyeva sup18supffluorodeoxyglucosepositronemissiontomographycombinedwithcomputedtomographyforthepredictionofradioiodinetherapyresponseinpatientswithmetastaticdifferentiatedthyroidcancer AT pigarbuzov sup18supffluorodeoxyglucosepositronemissiontomographycombinedwithcomputedtomographyforthepredictionofradioiodinetherapyresponseinpatientswithmetastaticdifferentiatedthyroidcancer AT vvkrylov sup18supffluorodeoxyglucosepositronemissiontomographycombinedwithcomputedtomographyforthepredictionofradioiodinetherapyresponseinpatientswithmetastaticdifferentiatedthyroidcancer |